Interaction between RNA interference and RNA editing pathways
Interaction between RNA interference and RNA editing pathways
批准号:
8197917
负责人:
KAZUKO NISHIKURA
金额:
$43.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-07-01 至 2013-11-30
关键词:
ADAR1AdenosineAdultApoptosisApplications GrantsBindingBiochemicalBiogenesisBiologicalCancer BiologyCellsCloningCodeComplementary DNAComplexCytoprotectionDRADA2b proteinDouble-Stranded RNAEmbryoEmbryonic DevelopmentFamily memberFibroblastsFunctional RNAFundingGene FamilyGene SilencingGenesGenetic TranscriptionGenomeGlutamate ReceptorGoalsGrantHealthHepatitisHomodimerizationHumanHuman CloningInosineIntronsInvertebratesIon ChannelKnock-in MouseKnowledgeLiverMalignant NeoplasmsMammalian CellMediatingMicroRNAsMolecularMolecular ProfilingMusMutationNaturePathway interactionsPhenotypeProcessProtein BiosynthesisProteinsPseudogenesRNARNA EditingRNA InterferenceRNA-specific adenosine deaminase 3RegulationRepetitive SequenceReportingResearchRetrotransposonRodentRoleSerumSmall Interfering RNASmall RNAStressSystemTestingTimeTissuesTranscriptTumor Suppressor GenesUntranslated RegionsWorkcomparativedsRNA adenosine deaminasehuman DICER1 proteinhuman diseasememberoverexpressionserotonin receptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): One type of RNA editing involves the conversion of adenosine residues into inosine in double-stranded RNA (dsRNA) through the action of adenosine deaminase acting on RNA (ADAR). Three ADAR gene family members (ADAR1-3) have been identified in humans and rodents. When A I RNA editing occurs within a coding sequence, synthesis of proteins not directly encoded by the genome can result, as demonstrated with transcripts of glutamate receptor (GluR) ion channels and 5-HT2C serotonin receptors. However, the most common targets for A I editing are non-coding RNAs that contain inverted repeats of repetitive elements such as Alu and LINE located within introns and 3' UTRs. The biological significance of non-coding, repetitive RNA editing is largely unknown. The overall goal of this project is to better understand the biological significance of A I RNA editing. During the past 17 years, this grant has enabled us to clone ADAR1, the first identified member of the ADAR gene family. This in turn has led to the identification and cloning of ADAR2 and ADAR3. Furthermore, we have created an ADAR1-/- mutation in mice that causes widespread apoptosis and consequent embryonic lethal phenotypes. Our results suggest that ADAR1 is critically important for survival of numerous tissues by editing a currently unknown target dsRNA(s). During the current grant support period, we found that both ADAR1 and ADAR2 edit specific adenosine residues of certain miRNA precursor dsRNAs (pri-miRNAs). Editing of pri- miRNAs results in inhibition of their processing or expression of edited mature miRNAs that silence genes different from those targeted by unedited miRNAs. Our findings revealed a previously unknown role for A I RNA editing in miRNA-mediated gene silencing. Finally, our preliminary results indicate that ADAR1 associates with certain miRNA-induced silencing complex (miRISC) member proteins. Thus, our studies strongly indicate that the RNAi and RNA editing pathways interact in mammalian cells. Therefore, in the proposed work embodies in this application, we will focus our research efforts on this RNAi and RNA editing interaction as our main thrust. Specifically, we will determine: 1) the significance of certain miRNAs that are edited during embryonic development for regulation of apoptosis; 2) the significance of A I editing of repetitive non-coding RNAs for control of endogenous siRNA (esiRNA) expression; and 3) the significance of ADAR1 interaction with the miRISC member proteins. PUBLIC HEALTH RELEVANCE: Recent studies indicate that mutations and mis-expression of miRNAs correlate with various human cancers. Certain miRNAs can function as tumor suppressors and oncogenes. Thus, the current grant proposal to investigate the effect of A&I editing of miRNAs and siRNAs has relevance to cancer biology. Our research focuses also on apoptosis, which is highly relevant to many human diseases including cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stress Response Functions of ADAR1 Regulated by MAP Kinases
-
批准号:10330572
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2019
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Stress Response Functions of ADAR1 Regulated by MAP Kinases
-
批准号:10093094
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2019
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
-
批准号:8625434
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
-
批准号:9187428
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2014
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Cardiogenesis by microRNA Editing
-
批准号:7934485
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Control of Cardiogenesis by microRNA Editing
-
批准号:7810127
-
项目类别:
-
资助金额:$49.02万
-
财政年份:2009
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Characterization of TRBP-containing complexes
-
批准号:7146839
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2006
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6746917
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6465404
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6833858
-
项目类别:
-
资助金额:$4.45万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6912766
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
Functions of ADARI RNA Editase in Erythropoiesis
-
批准号:6623407
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2002
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6477406
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6336431
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2000
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6344744
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2000
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6217497
-
项目类别:
-
资助金额:$21.6万
-
财政年份:1999
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6103321
-
项目类别:
-
资助金额:$21.6万
-
财政年份:1999
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6269811
-
项目类别:
-
资助金额:$21.71万
-
财政年份:1998
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6296149
-
项目类别:
-
资助金额:$21.71万
-
财政年份:1998
-
负责人:KAZUKO NISHIKURA
-
依托单位:
EFFECTS OF DSRNA ADENOSINE DEAMINASE (DRADA) ON ANTISENSE RNA STRATEGY
-
批准号:6237788
-
项目类别:
-
资助金额:$21.67万
-
财政年份:1997
-
负责人:KAZUKO NISHIKURA
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: